Literature DB >> 1067655

Polyploidy of the bone marrow.

G H Borgström, P Vuopio, A De la Chapelle.   

Abstract

In a consecutive series of 841 patients whose bone marrows were cytogenetically investigated because of verified or suspected haematological disease, 11 patients were found to have at least 10% polyploid bone marrow mitoses. The chromosome numbers varied greatly between the cells of the same patients and between the patients. In 4 cases, the number was nearly or exactly tetraploid and in 1 patient a prevalent octaploid line was seen. Structurally abnormal marker chromosomes were seen in 8 of the patients. A total of 31 bone marrow chromosome counts were performed on a young woman with acute myelomonocytic leukaemia who had had several drug-induced remissions during the 3 1/2 years of disease. The results were related to the clinical findings. On several occasions a clear-cut correlation was noted between high proportions (nearly 100%) of polyploid cells and relapse on the one hand and low proportions (as low as 0%) of polyploids and remission on the other. Of the 11 patients, 2 had chronic myeloid leukaemia, 3 acute myelomonocytic leukaemia, 3 acute myeloid leukaemia and a further 3 some other malignant haematological disorders. We conclude that polyploidy is a feature associated with rare cases of leukaemia and other malignant diseases. It is often a sign of a poor prognosis.

Entities:  

Mesh:

Year:  1976        PMID: 1067655     DOI: 10.1111/j.1600-0609.1976.tb01165.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  2 in total

1.  Fluorescence in-situ hybridisation on biopsies from clam ileocystoplasties and on a clam cancer.

Authors:  K D Ivil; S H Doak; S A Jenkins; E M Parry; H G Kynaston; J M Parry; T P Stephenson
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

2.  Polyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing disease.

Authors:  Nisha R Singh; Christine M Morris; Mary Koleth; Kelly Wong; Christopher M Ward; William S Stevenson
Journal:  Mol Cytogenet       Date:  2013-12-17       Impact factor: 2.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.